首页> 外文期刊>Вестник офтальмологии >The significance of removing the anterior hyaloid membrane and lens capsule in the course of combined surgery in proliferative diabetic retinopathy
【24h】

The significance of removing the anterior hyaloid membrane and lens capsule in the course of combined surgery in proliferative diabetic retinopathy

机译:增生性糖尿病视网膜病变联合手术中去除玻璃体前膜和晶状体囊膜的意义

获取原文
获取原文并翻译 | 示例
           

摘要

Due to the specificity of complications and to peculiarities of the surgical approach the principles of cataract surgery have been changing, when combined with transciliary vitrectomy. The postoperative complications in surgery for proliferative diabetic retinopathy (PDR) are often related with development of proliferative processes in the anterior eye segment. Therefore, a scope and a type of surgical manipulations in the anterior segment affect, to a great extent, the stability of the obtained result. IOL implantation is indicated for a limited category of patients with PDR. The feasibility of preserving the anatomic separation of the eye into the anterior and posterior segments by the anterior hyaloid membrane and by the posterior lens capsule is decisive in combined PDR surgery. In combined surgeries for PDR, transciliary lensectomy can be a method of choice for patients, who do not need IOL implantation.
机译:由于并发症的特殊性和手术方法的特殊性,与经睫状玻璃体切除术联合使用时,白内障手术的原则已经发生了变化。增生性糖尿病视网膜病变(PDR)的手术后并发症通常与前眼节中增生过程的发展有关。因此,前节段的手术操作的范围和类型在很大程度上影响所获得结果的稳定性。人工晶状体植入适用于PDR患者的有限类别。在联合PDR手术中,通过前透明玻璃膜和后晶状体囊保留眼睛在前,后段的解剖分离的可行性是决定性的。在PDR联合手术中,对于不需要IOL植入的患者,经睫状体晶状体摘除术可能是一种选择的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号